Skip to Main Content

Patient-centred Hereditary Ovarian Cancer Prevention and Survivorship Care in Canada

Precision medicine for patients with co-existent ovarian and endometrial cancer: the COMPARE trial

Enabling a Phase I Clinical Trial of a Novel CAR-T Cell Therapy for Ovarian Cancer

Improving access to opportunistic salpingectomy in Canada: a collaboration with the Ovarian Cancer Observatory

Development and characterization of humanized patient-derived xenograft models for ovarian cancer

Uncovering novel metabolic regulators of T cell function

Evaluation of novel parent-of-origin detection sequencing tool

Testing a novel treatment target in clear cell ovarian cancer

Establishing a national registry of clear cell and mucinous ovarian cancers

Anti-estrogen therapy and ER/PR expression in low-grade serous ovarian cancer